Drug Screening Market is Dominated by North America, followed by Europe, Asia-Pacific, and the Rest of the World

The global drug and alcohol testing market is expected to reach $6.3 billion by 2019 from $4 billion in 2014, growing at a CAGR of 9.5% from 2014 to 2019.

The report Drug Screening Market by Products and Services (Immunoassay Analyzers, Chromatography, Breath Analyzers, Rapid Testing Devices, Assay Kits and Reagents), Sample Type (Urine, Breath, Saliva, Hair, Blood, Skin, Sweat) – Global Forecast to 2019”, provides a detailed overview of the major drivers, restraints, challenges, opportunities, current market trends, and strategies impacting the drug and alcohol testing market along with estimates and forecasts of the revenue and share analysis.

The global drug and alcohol testing market is expected to reach $6.3 billion by 2019 from $4 billion in 2014, growing at a CAGR of 9.5% from 2014 to 2019.

The report segments the drug and alcohol testing market on the basis of products and services, sample types, end users, and regions. In the samples segment, urine samples accounted for the largest share in 2014. The breath sample segment will grow at the highest CAGR in the forecast period. Breath testing is the most common test performed for driving under influence (DUI) cases. Factors such as the rise in the number of roadside accidents due to DUI and government initiatives to curb DUI are the factors driving the growth of drug and alcohol testing market for breath testing. The oral fluid testing segment has also gained prominence in the market. This can be attributed to the noninvasive nature of this test where samples can be collected under direct observation, and thus the adulteration of said sample can be prevented. Furthermore, with oral fluid testing, the concentrations of many drugs can be closely correlated with blood concentrations.

Based on region, the market is dominated by North America, followed by Europe, Asia-Pacific, and the Rest of the World (RoW). North America is estimated to account for the largest share of the market in 2014, while Asia-Pacific is likely to witness the highest growth in this market.

North America dominates the drug screening market, with the U.S. accounting for a major market share. However, the Asia-Pacific is poised to grow at the highest CAGR during the forecast period. Growth in the Asian market will be driven by factors such as growing number of drug addicts, rising vehicle base in China and India (increased probability of road accidents due to DUI), development of advanced drug and alcohol screening devices in Japan, rising awareness regarding the importance of drug and alcohol screening, and increasing disposable income levels in various countries in Asia.

Ask for Free Sample Pages! http://www.marketsandmarkets.com/requestsample.asp?id=162987773

Key players in the Drug and Alcohol Testing Market include:
Quest Diagnostics (U.S.)
Laboratory Corporation of America Holdings (U.S.)
Alere, Inc., (U.S.)
Roche Diagnostics (Switzerland)
Thermo Fisher Scientific, Inc. (U.S.)
Drägerwerk AG & Co. KGaA (Germany)
Siemens Healthcare (Germany)
Express Diagnostics Intl Inc. (U.S.)
Shimadzu (Japan), and MPD, Inc. (U.S.)

Media Contact
Company Name: MarketsandMarkets
Contact Person: Mr. Rohan
Email: Send Email
Phone: 1-888-600-6441
Address:701 Pike Street, Suite 2175
City: Seattle
State: Washington
Country: United States
Website: http://www.marketsandmarkets.com/